Clevidipine in acute heart failure: Results of the A Study of Blood Pressure Control in Acute Heart Failure-A Pilot Study (PRONTO).

[1]  M. Drazner,et al.  2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2013, Journal of the American College of Cardiology.

[2]  P. Levy,et al.  Acute Heart Failure Treatment , 2008, Current Emergency and Hospital Medicine Reports.

[3]  L. A. Bonet,et al.  ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 , 2012, Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir.

[4]  P. Ponikowski,et al.  Early dyspnoea relief in acute heart failure: prevalence, association with mortality, and effect of rolofylline in the PROTECT Study. , 2011, European heart journal.

[5]  W. Gibler,et al.  Acute heart failure syndromes: emergency department presentation, treatment, and disposition: current approaches and future aims: a scientific statement from the American Heart Association. , 2010, Circulation.

[6]  P. Ponikowski,et al.  Dyspnoea and worsening heart failure in patients with acute heart failure: results from the Pre-RELAX-AHF study , 2010, European journal of heart failure.

[7]  Nancy M Albert,et al.  HFSA 2010 Comprehensive Heart Failure Practice Guideline. , 2010, Journal of cardiac failure.

[8]  P. Ponikowski,et al.  Dyspnoea in patients with acute heart failure: an analysis of its clinical course, determinants, and relationship to 60‐day outcomes in the PROTECT pilot study , 2010, European journal of heart failure.

[9]  K. Sliwa,et al.  The impact of early standard therapy on dyspnoea in patients with acute heart failure: the URGENT-dyspnoea study. , 2010, European heart journal.

[10]  D. Mozaffarian,et al.  Executive summary: heart disease and stroke statistics--2010 update: a report from the American Heart Association. , 2010, Circulation.

[11]  D. Mozaffarian,et al.  Heart disease and stroke statistics--2010 update: a report from the American Heart Association. , 2010, Circulation.

[12]  G. Fonarow,et al.  Early vasoactive drugs improve heart failure outcomes. , 2009, Congestive heart failure.

[13]  W. Peacock,et al.  Intravenous therapy for hypertensive emergencies, part 2. , 2009, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[14]  S. Collins,et al.  Acute Decompensated Heart Failure , 2009 .

[15]  M. Gheorghiade,et al.  Acute heart failure syndromes , 2009, Journal of the American College of Cardiology.

[16]  F. Ginsberg.  Timing of Immunoreactive B-Type Natriuretic Peptide Levels and Treatment Delay in Acute Decompensated Heart Failure: An ADHERE (Acute Decompensated Heart Failure National Registry) Analysis , 2009 .

[17]  C. Yancy,et al.  Society of Chest Pain Centers Recommendations for the evaluation and management of the observation stay acute heart failure patient: a report from the Society of Chest Pain Centers Acute Heart Failure Committee. , 2008, Critical pathways in cardiology.

[18]  M. Gheorghiade,et al.  A proposal to standardize dyspnoea measurement in clinical trials of acute heart failure syndromes: the need for a uniform approach. , 2008, European heart journal.

[19]  A. Parkhomenko,et al.  Practical recommendations for prehospital and early in-hospital management of patients presenting with acute heart failure syndromes. , 2008, Critical care medicine.

[20]  P. Levy,et al.  Treatment of severe decompensated heart failure with high-dose intravenous nitroglycerin: a feasibility and outcome analysis. , 2007, Annals of emergency medicine.

[21]  G. Filippatos,et al.  An introduction to acute heart failure syndromes: definition and classification , 2007, Heart Failure Reviews.

[22]  Luigi Tavazzi,et al.  Acute Heart Failure Syndromes: Current State and Framework for Future Research , 2005, Circulation.

[23]  A. Hoes,et al.  Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. , 2005, European heart journal.

[24]  K. Adams,et al.  Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). , 2005, American heart journal.

[25]  K. Dickstein,et al.  [Executive summary of the guidelines on the diagnosis and treatment of acute heart failure]. , 2005, Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology.

[26]  L. Rydén,et al.  Pharmacodynamic, pharmacokinetic and clinical effects of clevidipine, an ultrashort-acting calcium antagonist for rapid blood pressure control. , 2006, Cardiovascular drug reviews.

[27]  Zvi Vered,et al.  The role of cardiac power and systemic vascular resistance in the pathophysiology and diagnosis of patients with acute congestive heart failure , 2003, European journal of heart failure.

[28]  Z. Vered,et al.  Acute heart failure: a novel approach to its pathogenesis and treatment , 2002, European journal of heart failure.

[29]  James B. Young.  Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: A randomized controlled trial , 2002 .

[30]  P. Poole‐Wilson.  Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial. , 2002 .

[31]  K. Kataoka,et al.  Serial circulating concentrations of c‐reactive protein, interleukin (il)‐4, and il‐6 in patients with acute left heart decompensation , 1999, Clinical cardiology.

[32]  B. Pohar,et al.  Influence of hemodynamic changes on neuroendocrine response in acute heart failure. , 1997, International journal of cardiology.

[33]  M. Feldman,et al.  Bolus intravenous nitroglycerin predominantly reduces afterload in patients with excessive arterial elastance. , 1993, Journal of the American College of Cardiology.

[34]  R. Wuerz,et al.  Effects of prehospital medications on mortality and length of stay in congestive heart failure. , 1992, Annals of emergency medicine.